Description
Klopazs (Clonazepam) 2 mg
Klopazs 2 mg is a tablet medicine containing clonazepam, a benzodiazepine. Clonazepam is used in clinical practice as an anticonvulsant and, in some settings, for panic disorder. This summary is based on established prescribing information for clonazepam tablets and related regulatory labels.
Active Ingredient and Medicine Class
The verified active ingredient is clonazepam. It belongs to the benzodiazepine class of medicines. Benzodiazepines act on the central nervous system and are known for anticonvulsant, sedative, anxiolytic and muscle-relaxant properties.
Established Medical Uses
Official labeling for clonazepam tablets identifies use in certain seizure disorders, including Lennox-Gastaut syndrome, akinetic seizures and myoclonic seizures. It may also be indicated for panic disorder, with or without agoraphobia, depending on the specific approved product label. These are established medical uses; other uses described in the scientific literature are not necessarily approved indications.
How It Works
Clonazepam is believed to enhance the activity of gamma-aminobutyric acid (GABA), the brain’s main inhibitory neurotransmitter. By strengthening GABA-mediated inhibition, it reduces excessive neuronal firing, which helps explain its anticonvulsant and anti-anxiety effects. The exact mechanism responsible for all clinical effects is not fully defined.
Important Safety Information
Clonazepam is not suitable for everyone. It is contraindicated in people with a history of sensitivity to benzodiazepines, significant liver disease, and acute narrow-angle glaucoma. Important precautions include the risk of sedation, impaired alertness, respiratory depression, abuse, misuse, physical dependence and withdrawal reactions. Concomitant use with opioids can cause profound sedation, respiratory depression, coma and death. Alcohol and other central nervous system depressants can increase these risks. Caution is also warranted in older adults and in patients with liver or kidney impairment.
Possible Side Effects
Common or clinically important adverse effects associated with clonazepam include drowsiness, dizziness, fatigue, impaired coordination, confusion and cognitive slowing. Benzodiazepines may also cause paradoxical reactions such as agitation, irritability, aggression, anxiety, hallucinations or psychotic symptoms in some people. More serious reactions can include respiratory depression, worsening depression, suicidal thoughts or behaviour, dependence and withdrawal symptoms, including seizures after abrupt discontinuation.
Scientific Evidence
Clinical trial evidence in the prescribing record supports clonazepam’s benefit in panic disorder over short treatment periods, with reductions in panic attacks compared with placebo. In seizure disorders, clonazepam has long-standing use as an anticonvulsant, particularly in specific generalized seizure types. More recent review literature also highlights its established pharmacology, along with the clinically important concerns of tolerance, dependence and misuse that may limit long-term usefulness. Overall, the evidence base supports efficacy in selected conditions, but the safety profile requires careful consideration.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, product label or individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration / DailyMed. Clonazepam Tablets, USP prescribing information. View official prescribing information
- U.S. Food and Drug Administration. Klonopin Tablets (clonazepam) label. View FDA label
- Vinícius Dokkedal-Silva et al. Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use. Harvard Review of Psychiatry, 2019. View scientific article
- Clonazepam. PubMed clinical review article. StatPearls, 2020. View scientific article
